Gene expression changes in 32DWT1 cells treated with ZnCl2
Gene . | UniGene no. . | Fold change with ZnCl2 . |
|---|---|---|
| Caveolin 2 | Mm.31915 | 0.15 |
| Dffa | Mm.41433 | 0.26 |
| Pdcd11 | Mm.41166 | 0.32 |
| CIDE-A | Mm.449 | 0.36 |
| RBBP4 | Mm.12145 | 2.67 |
| IGF-II | Mm.3862 | 2.96 |
| PTEN | Mm.220979 | 3.33 |
| Cyclin A2 | Mm.4189 | 4.2 |
| 14-3-3 η | Mm.332314 | 4.22 |
| Sfrp5 | Mm.103731 | 4.55 |
| PCNA | Mm.7141 | 5.02 |
| CDK4 | Mm.6839 | 6.23 |
| Granzyme B | Mm.14874 | 10.72 |
| NAIP | Mm.89961 | 11.2 |
| ODC | Mm.34102 | 16.95 |
| CBP | Mm.132238 | 17.53 |
| MT-2 | Mm.147226 | 39 |
| Granzyme A | Mm.15510 | — |
| Sfrp2 | Mm.19155 | — |
| BID | Mm.235081 | — |
| A1 | Mm.196770 | — |
| CDK6 | Mm.31672 | — |
| Thrombospondin | Mm.4159 | — |
| APEX | Mm.203 | — |
Gene . | UniGene no. . | Fold change with ZnCl2 . |
|---|---|---|
| Caveolin 2 | Mm.31915 | 0.15 |
| Dffa | Mm.41433 | 0.26 |
| Pdcd11 | Mm.41166 | 0.32 |
| CIDE-A | Mm.449 | 0.36 |
| RBBP4 | Mm.12145 | 2.67 |
| IGF-II | Mm.3862 | 2.96 |
| PTEN | Mm.220979 | 3.33 |
| Cyclin A2 | Mm.4189 | 4.2 |
| 14-3-3 η | Mm.332314 | 4.22 |
| Sfrp5 | Mm.103731 | 4.55 |
| PCNA | Mm.7141 | 5.02 |
| CDK4 | Mm.6839 | 6.23 |
| Granzyme B | Mm.14874 | 10.72 |
| NAIP | Mm.89961 | 11.2 |
| ODC | Mm.34102 | 16.95 |
| CBP | Mm.132238 | 17.53 |
| MT-2 | Mm.147226 | 39 |
| Granzyme A | Mm.15510 | — |
| Sfrp2 | Mm.19155 | — |
| BID | Mm.235081 | — |
| A1 | Mm.196770 | — |
| CDK6 | Mm.31672 | — |
| Thrombospondin | Mm.4159 | — |
| APEX | Mm.203 | — |
Listed are genes noted to be significantly up- or down-regulated upon WT1 induction in 32DWT1 cells, but not (with the exception of metallothionein) in 32DV4 cells treated with ZnCl2. Metallothionein was up-regulated in control cells, which is the expected response to treatment with heavy metal.
— indicates a gene that was expressed only after treatment with ZnCl2.